Ahmed F Y, Gore M E, Shepherd J, Fisher C
Royal Marsden Hospital, London, UK.
Clin Oncol (R Coll Radiol). 1996;8(2):125-6. doi: 10.1016/s0936-6555(96)80122-1.
A patient with a residual mature solid ovarian teratoma, which underwent malignant transformation to an adenocarcinoma 10 years after previous successful treatment, is presented. This case history illustrates that patients with residual mature disease require long term follow-up.
本文报告了一名患有残留成熟实性卵巢畸胎瘤的患者,该患者在先前成功治疗10年后发生恶性转化为腺癌。该病例史表明,患有残留成熟疾病的患者需要长期随访。